Commentary: Shutting the Door After Antegrade Femoral Arteriotomy: Should You Push, Clip, Tie, or Plug?

Retrograde popliteal access as bail‐out strategy for challenging occlusions of the superficial femoral artery: A multicenter registry

“…In case of inability to cross the occlusion or to intraluminal re-entry by both femoral and popliteal route, no further attempt was conducted and the procedure was interrupted. Hemostasis at the femoral access was achieved by either manual compression or closure devices, whereas hemostasis at the popliteal or brachial accesses was managed with manual compression only in all cases, with compression typically lasting 3 minutes for each sheath French [20].…”

Commentary: Use of the 8-F Angio-Seal Vascular Closure Device for Much Larger Sheaths: Successfully Fitting a Square Peg Into a Round Hole?

“…2 Other vascular closure devices are available for smaller sheaths, such as St. Jude Medical's 6-F and 8-F Angio-Seal, Abbott Vascular's 6-F StarClose, and others, which collectively may have several advantages over suture-based devices. 3,4 Indeed, Angio-Seal probably represents the most commonly used vascular closure device, given its safety, non-invasiveness, ease of use, and versatility. 5,6 Accordingly, Angio-Seal has been deployed with satisfactory results after antegrade femoral puncture, as well as in axillary, brachial, carotid, superficial femoral, and popliteal arteries.…”

Commentary: Using Vascular Closure Devices Outside the Operating Room:No Reason for Homesickness!

“…Vascular closure devices represent a mainstay in the management of femoral arteriotomy, given their ease of use, favorable risk-benefit profile, and significant benefits in terms of patient comfort, early ambulation, and time savings for personnel in comparison to standard manual compression. 1 Despite the availability of other access sites and non-implantable devices for femoral hemostasis, 2–5 ongoing refinements in products and techniques have recently further improved the clinical performance of vascular closure devices. This is also supported by the safe use of such devices in patently off-label indications, such as brachial, carotid, popliteal, or stented femoral arteries.…”